⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

TECH

Bio-Techne Corporation

Healthcare · Biotechnology

72.25USD

-0.0600 (-0.08%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End06/2026
Last Quarter End06/2026 Q4
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 72.25
P/E62.3
Dvd Ind Yld0.4%
P/B5.37
P/S9.3
Curr EV/T12M EBITDA32.5
Mkt Cap (USD)11.3B
Curr EV (USD)11.4B
2)

Per Share Data

EPS T12M1.15
DPS0.32
Bk Val Per Sh13.51
Rev/Sh7.74
Cash/Sh1.69
Curr Shares Out156.8M
FCF/Sh1.68
3)

Cash Flow Analysis

P/CF38.8
Curr P/FCF43.0
CF/NI1.6
Dvd P/O27.4%
Cash Gen/Cash Reqd3.7
Csh Dvd Cov5.9
CFO/Sales24.0%
Eff Interest Rate77.0%
4)

Growth Potential

Dil EPS 1Y Gr152.2%
Cap 1Y Gr9.9%
BPS 1Y Gr11.8%
R&D To Sales—
Retention Rate72.6%
Rev 1Y Gr-0.4%
FCF 1Y Gr2.6%
Assets 1Y Gr1.1%
5)

Profitability

EBITDA0.3B
EBIT0.3B
Operating Margin20.7%
Pretax Margin19.8%
Net Margin15.0%
ROA7.1%
ROE9.0%
ROC7.9%
Asset Turnover0.47
6)

Structure

Current Ratio4.55
Quick Ratio2.95
Debt/Assets11.2%
Debt/Com Eq13.7%
Net Debt/EBITDA0.07
Tot Debt/Capital12.1%
Gross Margin65.8%
EBIT/Int Exp26.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.